Shares of Illumina Inc. (NASDAQ: ILMN) struck a new 52-week high today after the San Diego, California-based company reported its financial results for the second quarter. Illumina, which is engaged in the development and manufacture of life science tools and integrated systems for the analysis of genetic variation and function, reported non-GAAP earnings of $0.43 per share for the quarter, compared to $0.40 per share reported for the same period in the previous year. Analysts were expecting ILMN to report earnings of $0.40 per share.
Continue reading Major Movers on July 24; ILMN, PNRA, HBI, MFB